This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board to approve September 2026 quarter and half-year results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts less than Nifty Microcap 250 and 1.8 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 2, 2026, to approve the company's unaudited financial results for the quarter and half-year ended September 30, 2026. No financial figures were provided.
This is only a meeting notice. Shareholders should wait for the results before assessing the company's performance or likely stock reaction.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹47.55 Cr | ₹0.00 Cr | turned positive |
| Operating profit | −₹1.51 Cr | −₹0.25 Cr | loss widened |
| Profit after tax | ₹1.50 Cr | −₹0.47 Cr | turned positive |
| EBITDA margin | 3.5% | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.